About
Our Mission
Leadership
Partners
Our Technologies
TALEN® Technology
Gene Editing
PulseAgile Technology
Patents
Pipeline
Products
Clinical Indications
Manufacturing
Investors
Press Releases
Corporate Presentation
Scientific Presentations
Scientific Publications
Events and Webcasts
2021 Cellectis Innovation Days
Stock Information
Corporate Governance
Governance Documents
Board of Directors & Committee Members
Shareholders Meeting
SEC Filings
Contact
IR Inquiries
Email Alerts
Investor FAQ
Careers
Our Culture
Job Opportunities
Contact us
fr
Press Releases
Our latest news and press releases
All
2023
2022
2021
2020
2019
2018
10
Dec
2018
16:30 E.S.T.
Cellectis Appoints William Monteith as Senior Vice President U.S. Manufacturing
Read more
13
Nov
2018
16:30 E.S.T.
Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2018
Read more
19
Sep
2018
16:30 E.S.T.
CAR-T Pioneer Dr. Stephan A. Grupp to Join Cellectis Clinical Advisory Board
Read more
18
Sep
2018
16:30 E.S.T.
Calyxt Appoints CEO, Jim Blome, Former President & CEO of Bayer CropScience LP
Read more
22
Aug
2018
08:00 E.S.T.
Calyxt Names Biotech Veteran and Board of Directors Member Dr. Yves J. Ribeill as Interim CEO
Read more
02
Aug
2018
16:30 E.S.T.
Cellectis Appoints Stefan Scherer M.D., Ph.D., as Senior Vice President Clinical Development and Deputy Chief Medical Officer
Read more
01
Aug
2018
16:30 E.S.T.
Cellectis Reports Financial Results for 2nd Quarter and First Six Months 2018
Read more
27
Jun
2018
16:30 E.S.T.
Cellectis S.A. Reports Results from Annual General Meeting Held on June 26, 2018
Read more
12
Jun
2018
16:30 E.S.T.
Cellectis Publishes Novel Methods to Improve the Clinical Use of Chimeric Antigen Receptor T-Cell Therapy in Scientific Reports
Read more
08
Jun
2018
17:45 E.S.T.
Shareholders’ General Meeting of June 26, 2018
Read more